Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 235

1.

Reexamining the Association of Body Mass Index With Overall Survival Outcomes After Liver Transplantation.

Chang SH, Liu X, Carlsson NP, Park Y, Colditz GA, Garonzik-Wang JM, Chapman WC, Wellen JR, Doyle MB, Alhamad T.

Transplant Direct. 2017 Jun 12;3(7):e172. doi: 10.1097/TXD.0000000000000681. eCollection 2017 Jul.

2.

Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.

Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW.

Ann Surg. 2017 Sep;266(3):525-535. doi: 10.1097/SLA.0000000000002381.

PMID:
28654545
3.

Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.

Zheng J, Chou JF, Gönen M, Vachharajani N, Chapman WC, Majella Doyle MB, Turcotte S, Vandenbroucke-Menu F, Lapointe R, Buettner S, Groot Koerkamp B, Ijzermans JNM, Chan CY, Goh BKP, Teo JY, Kam JH, Jeyaraj PR, Cheow PC, Chung AYF, Chow PKH, Ooi LLPJ, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Lee SY.

Ann Surg. 2017 Jul 22. doi: 10.1097/SLA.0000000000002360. [Epub ahead of print]

PMID:
28650354
4.

Development of immune response to tissue-restricted self-antigens in simultaneous kidney-pancreas transplant recipients with acute rejection.

Gunasekaran M, Vachharajani N, Gaut JP, Maw TT, Delos Santos R, Shenoy S, Chapman WC, Wellen J, Mohanakumar T.

Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13009. Epub 2017 Jun 21.

PMID:
28639386
5.

LI-RADS and transplantation for hepatocellular carcinoma.

Tang A, Fowler KJ, Chernyak V, Chapman WC, Sirlin CB.

Abdom Radiol (NY). 2017 Jun 13. doi: 10.1007/s00261-017-1210-8. [Epub ahead of print] Review.

PMID:
28612162
6.

Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome.

Ghazarian M, Revelo XS, Nøhr MK, Luck H, Zeng K, Lei H, Tsai S, Schroer SA, Park YJ, Chng MHY, Shen L, D'Angelo JA, Horton P, Chapman WC, Brockmeier D, Woo M, Engleman EG, Adeyi O, Hirano N, Jin T, Gehring AJ, Winer S, Winer DA.

Sci Immunol. 2017 Apr 21;2(10). pii: eaai7616. doi: 10.1126/sciimmunol.aai7616.

7.

Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver Transplantation.

Xu M, Doyle MM, Banan B, Vachharajani N, Wang X, Saad N, Fowler K, Brunt EM, Lin Y, Chapman WC.

J Am Coll Surg. 2017 Jul;225(1):28-40. doi: 10.1016/j.jamcollsurg.2017.03.015. Epub 2017 Apr 9.

PMID:
28400300
8.

Liver Transplantation for Malignant Primary Pediatric Hepatic Tumors.

Khan AS, Brecklin B, Vachharajani N, Subramanian V, Nadler M, Stoll J, Turmelle Y, Lowell JA, Chapman WC, Doyle MM.

J Am Coll Surg. 2017 Jul;225(1):103-113. doi: 10.1016/j.jamcollsurg.2017.02.006. Epub 2017 Feb 20.

PMID:
28232059
9.

Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.

Chapman WC, Brown RS Jr, Chavin KD, Sudan D, Koneru B, Junge G, Dong G, Patel D, Teperman L, Fung JJ.

Transplantation. 2017 Feb;101(2):341-349. doi: 10.1097/TP.0000000000001524.

10.

Cutting Edge: Human CD49e- NK Cells Are Tissue Resident in the Liver.

Aw Yeang HX, Piersma SJ, Lin Y, Yang L, Malkova ON, Miner C, Krupnick AS, Chapman WC, Yokoyama WM.

J Immunol. 2017 Feb 15;198(4):1417-1422. doi: 10.4049/jimmunol.1601818. Epub 2017 Jan 16.

PMID:
28093522
11.

Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions.

Chapman WC, Garcia-Aroz S, Vachharajani N, Fowler K, Saad N, Lin Y, Wellen J, Tan B, Khan AS, Doyle MB.

J Am Coll Surg. 2017 Apr;224(4):610-621. doi: 10.1016/j.jamcollsurg.2016.12.020. Epub 2017 Jan 6.

PMID:
28069527
12.

Liver transplantation for hepatocellular carcinoma: current update on treatment and allocation.

Dageforde LA, Fowler KJ, Chapman WC.

Curr Opin Organ Transplant. 2017 Apr;22(2):128-134. doi: 10.1097/MOT.0000000000000385.

PMID:
27926548
13.

Physician-Patient Communication is Associated With Hepatocellular Carcinoma Screening in Chronic Liver Disease Patients.

Li DJ, Park Y, Vachharajani N, Aung WY, Garonzik-Wang J, Chapman WC.

J Clin Gastroenterol. 2016 Dec 1. [Epub ahead of print]

PMID:
27918312
14.

Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study.

Brauer DG, Strand MS, Sanford DE, Kushnir VM, Lim KH, Mullady DK, Tan BR Jr, Wang-Gillam A, Morton AE, Ruzinova MB, Parikh PJ, Narra VR, Fowler KJ, Doyle MB, Chapman WC, Strasberg SS, Hawkins WG, Fields RC.

HPB (Oxford). 2017 Feb;19(2):133-139. doi: 10.1016/j.hpb.2016.11.002. Epub 2016 Dec 1.

PMID:
27916436
15.

Operative Site Drainage after Hepatectomy: A Propensity Score Matched Analysis Using the American College of Surgeons NSQIP Targeted Hepatectomy Database.

Brauer DG, Nywening TM, Jaques DP, Doyle MB, Chapman WC, Fields RC, Hawkins WG.

J Am Coll Surg. 2016 Dec;223(6):774-783.e2. doi: 10.1016/j.jamcollsurg.2016.09.004. Epub 2016 Oct 26.

PMID:
27793459
16.

Epidemiology of Bloodstream Infections in a Multicenter Retrospective Cohort of Liver Transplant Recipients.

Santos CA, Hotchkiss RS, Chapman WC, Olsen MA.

Transplant Direct. 2016 Feb 22;2(3):e67. doi: 10.1097/TXD.0000000000000573. eCollection 2016 Mar.

17.

Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.

Zaydfudim VM, Vachharajani N, Klintmalm GB, Jarnagin WR, Hemming AW, Doyle MB, Cavaness KM, Chapman WC, Nagorney DM.

Ann Surg. 2016 Oct;264(4):650-8. doi: 10.1097/SLA.0000000000001866.

PMID:
27433910
18.

Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody.

Xiao Z, Banan B, Xu M, Jia J, Manning PT, Hiebsch RR, Gunasekaran M, Upadhya GA, Frazier WA, Mohanakumar T, Lin Y, Chapman WC.

Transplantation. 2016 Jul;100(7):1480-9. doi: 10.1097/TP.0000000000001186.

PMID:
27331362
19.

HPB Surgery: The Specialty is Here to Stay, but the Training is in Evolution.

D'Angelica MI, Chapman WC.

Ann Surg Oncol. 2016 Jul;23(7):2123-5. doi: 10.1245/s10434-016-5230-3. Epub 2016 May 2. No abstract available.

PMID:
27138384
20.

Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation.

Leal JN, Bressan AK, Vachharajani N, Gonen M, Kingham TP, D'Angelica MI, Allen PJ, DeMatteo RP, Doyle MB, Bathe OF, Greig PD, Wei A, Chapman WC, Dixon E, Jarnagin WR.

J Am Coll Surg. 2016 May;222(5):766-79. doi: 10.1016/j.jamcollsurg.2016.01.046. Epub 2016 Jan 30.

Supplemental Content

Loading ...
Support Center